Press Releases

Isohelix and AutoGen sign a collaborative supply agreement

Isohelix, a specialist provider of DNA and RNA sampling and purification products, and AutoGen, Inc., a leading provider of nucleic acid extraction automation, have signed a far-reaching supply agreement.

CytoSMART redefines automated cell counting with a new fluorescence cell counter

Today CytoSMART Technologies has announced the release of its first fluorescence cell counter, CytoSMART Exact FL

MedAI Launches Integrated Drug Discovery Approaches to Solve In Silico Drug Discovery Problems

MedAI announces that it has launched integrated drug discovery approaches to help to solve in silico drug discovery challenges, such as problems arising from drug candidate compound screening, target profiling, compound structure scoring in de novo design, and other related calculations.

Formulationbio Provides Comprehensive Formulation Development and Analytical Services for the pharmaceutical Industry

Fully aware of the challenges that may arise from this process, Formulationbio recently announces that it now provides a comprehensive range of formulation development and analytical services for the pharmaceutical industry.

Main Products Provided at Alfa Chemistry Materials: In-Stock and Cost-Effective

For the convenience of customers, Alfa Chemistry Materials recently has sorted out seven categories of products as its main featured products, which can be easily found at the website.

Matexcel Offers a Wide Selection of Hydroxyapatite Products for Research Use

BioIVT Supports In Vitro Diagnostic Device Manufacturers Seeking to Meet New European Market Regulatory Requirements

The IVDR ((EU) 2017/746) provides new definitions of an IVD and changes how they are classified, monitored, and regulated with the intention of improving the quality, safety, and reliability of IVDs. Under the new regulations most IVDs will require certification via a notified body. In many cases, this will require sponsoring manufacturers to conduct associated testing and analytics with specimens from clinical collections and/or clinical trials.

NDA Group announces Christine Lind as the new VP of Commercial

NDA Group, a world-leading regulatory, drug development and medical device consultancy, has appointed Christine Lind as the new VP of Commercial.

Sygnature Discovery expands US presence with office in Bay Area biotech hub

Sygnature Discovery, a world-leading integrated drug discovery and non-clinical solutions provider, has expanded its US presence with a new office in South San Francisco’s biotech hub at Oyster Point.

GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent

GenNext Technologies, Inc., a growth-stage company that provides instrumentation, software and services to structural biology researchers within the biopharmaceutical industry, announced today that nearly $7M (US) in NIH grant awards has led to a seminal US patent for its novel technology.

DefiniGEN appoints Dr Ben Cons as Chairman of its Board

DefiniGEN, the world leader in human induced pluripotent stem cell (iPSC) differentiation and disease modelling, has announced the appointment of Dr Ben Cons as Chairman of the Board.

EchelonDx and Cradle Genomics Join Forces to Accelerate Development of Comprehensive Non-Invasive Prenatal Diagnostic Products

Echelon Diagnostics and Cradle Genomics today announced an agreement that will help accelerate the development of Cradle’s innovative cellular-based non-invasive prenatal diagnostic (NIPD) products.

Thermo Fisher Scientific Launches First-Ever GMP- and Cleanroom-Compatible CO2 Incubator

Thermo Fisher Scientific announced today the launch of the Thermo Scientific Heracell Vios CR CO2 Incubator that is designed to address the need of biotechnology, biopharmaceutical and clinical laboratories for high-performance systems that meet stringent cleanroom and cGMP standards.

Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes

Takara Bio Europe AB (TBEAB) has announced a licensing agreement with PanCryos, a pre-clinical stage biotech company.

Microbiosci Provides Microbial Metabolomics Services with Advanced Instruments and State-of-the-art Multivariate Data Analyses

MicrobioSeq Introduces Microbial Iso-Seq to Characterize the Diverse Landscape of Transcript Isoforms

Bioinformatics-Analysis Division of CD Genomics Introduces Single Cell Genome Analysis Services

British digital health start-up launches free app to help improve inhaler technique and reduce asthma attacks

Introducing Clip-Tone Buddy app to aid inhaler technique.

Cytel Announces New VP Scientific Strategy & Innovation to Further Drive Bayesian Innovation

Cytel Inc. has appointed renowned Bayesian clinical trial design specialist Dr Kyle Wathen as Vice President of Scientific Strategy and Innovation.

Sygnature Discovery appoints Dr. David Lustig to spearhead US expansion

Sygnature Discovery, a world-leading integrated drug discovery and non-clinical solutions provider, has appointed Dr. David Lustig to the role of Vice President Business Development - United States.